Education
About Us
Working with TipRanks
Follow Us
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
1276 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$52.50 - HK$60.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)6.46M
Market Cap
HK$374.92B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)47.6
Beta-0.58
Next Earnings
Aug 18, 2025EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend Yield0.36%
Share Statistics
EPS (TTM)0.32
Shares Outstanding258,197,600
10 Day Avg. Volume1,847,767
30 Day Avg. Volume6,461,033
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H News
PremiumCompany Announcements
Jiangsu Hengrui Gains Approval for Innovative Cancer Drug
PremiumCompany Announcements
Jiangsu Hengrui’s Innovative Antiemetic Drug Gains Approval
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
1276 FAQ
What was Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s price range in the past 12 months?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H lowest stock price was HK$52.50 and its highest was HK$60.50 in the past 12 months.
What is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s market cap?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s market cap is HK$374.92B.
When is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s upcoming earnings report date?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s upcoming earnings report date is Aug 18, 2025 which is in 49 days.
How were Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s earnings last quarter?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H released its earnings results on Apr 25, 2025. The company reported HK$0.321 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.321.
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H overvalued?
According to Wall Street analysts Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s price is currently Overvalued.
Does Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H pay dividends?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H does not currently pay dividends.
What is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s EPS estimate?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s EPS estimate is 0.15.
How many shares outstanding does Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H have?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has 258,197,600 shares outstanding.
What happened to Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s price movement after its last earnings report?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H reported an EPS of HK$0.321 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1276
Technical Analysis
CSPC Pharmaceutical Group
―
Wuxi Biologics (Cayman)
―
WuXi AppTec Co., Ltd. Class H
―
Hansoh Pharmaceutical Group Company Limited
―
BeiGene Ltd
―